Search results for "TUMOR"

showing 10 items of 6365 documents

New prognostic markers in neuroblastoma

2013

Introduction: The hallmark of neuroblastoma is its clinical and biological heterogeneity, with the likelihood of cure varying widely according to age at diagnosis, extent of disease and tumor biology. We hope this review will be useful for understanding part of the unfamiliar neuroblastoma codex. Areas covered: In the first part of this review, the authors summarize the currently used prognostic factors for risk-adapted therapy, with the focus on clinical management of neuroblastoma patients. In the second part, the authors discuss the evolving prognostic factors for future treatment schemes. A search of online medical research databases was undertaken focusing especially on literature publ…

medicine.medical_specialtyClinical variablesbusiness.industryTumor biologyBiochemistry (medical)Biomedical EngineeringAge at diagnosisExtent of diseaseGeneral MedicineBioinformaticsMedical researchmedicine.diseaseNeuroblastomaMolecular targetsMolecular MedicineMedicineBiomarker (medicine)businessIntensive care medicineExpert Opinion on Medical Diagnostics
researchProduct

Oral administration of taurolidine ameliorates chronic DSS colitis in mice.

2007

Taurolidine (TRD) has antimicrobial and anti-inflammatory properties. However, the anti-inflammatory effects of TRD in inflammatory bowel diseases (IBD) have not been investigated. Here, we have analyzed the toxicity of TRD after oral long-term application in mice and examined the impact of oral TRD in a dextran sulfate sodium (DSS) model of experimental colitis. Female C57/BL6 mice received TRD in various concentrations (0.1% to 0.4%) for 60 days. Toxicity was evaluated by use of a disease activity index (DAI) and histological examination of major metabolic organs. Furthermore, the impact of 0.2% TRD on a chronic DSS colitis was examined by daily DAI, histological crypt damage score (CDS),…

medicine.medical_specialtyColonTaurineAdministration OralGastroenterologyInflammatory bowel diseasechemistry.chemical_compoundMiceOral administrationInternal medicinemedicineMesenteric lymph nodesAnimalsColitisThiadiazinesbusiness.industryDextran SulfateInterleukinTaurolidinemedicine.diseaseColitisInflammatory Bowel DiseasesMice Inbred C57BLmedicine.anatomical_structurechemistryCyclooxygenase 2Bacterial TranslocationImmunologyToxicityCytokinesSurgeryTumor necrosis factor alphaFemaleLymph NodesbusinessJournal of investigative surgery : the official journal of the Academy of Surgical Research
researchProduct

Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers

2015

AbstractFluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) has become a routine imaging modality for many malignancies and its use is currently increasing. In the present review article, we will summarize the evidence for FDG-PET/CT use in digestive cancers (excluding neuroendocrine tumours), and review the existing recommendations. While PET/CT is nowadays considered to be an important tool in the initial workup of oesophageal and anal cancers, new data are emerging regarding its use in assessing therapeutic efficacy, radiotherapy treatment planning, and detection of recurrence in case of isolated tumour marker elevation. Moreover, PET/CT may help …

medicine.medical_specialtyColorectal cancerColonoscopyDigestive System NeoplasmsMultimodal ImagingPatient Care PlanningFluorodeoxyglucose positron emission tomographyFluorodeoxyglucose F18Pancreatic cancerHumansMedicinePositron Emission Tomography-Computed TomographyFluorine-18-fluorodeoxyglucoseHepatologymedicine.diagnostic_testbusiness.industryOesophageal cancerGastroenterologyPancreatic cancerRadiotherapy treatment planningPrognosismedicine.diseaseColorectal cancerFDG-PET/CTAnal canal cancerReview articleNeuroendocrine TumorsPositron-Emission TomographyPractice Guidelines as TopicRadiologyNeoplasm Recurrence LocalRadiopharmaceuticalsTomography X-Ray ComputedbusinessDigestive and Liver Disease
researchProduct

An update on medical management on Crohn's disease.

2014

The management of Crohn's disease (CD) is continuously evolving. New issues emerging from more recent studies could influence the decision-making process in clinical practice.The aim of this review article is to highlight critical issues on the management of CD, new evidence from clinical trials, long-term prospective studies and real life experience, beyond the current guidelines.The role of mucosal healing in clinical practice is uncertain, clinical remission remains the primary end point. The timing for the definition of steroid-resistant CD should be considered between 2 and 4 weeks. Early treatment strategy with immunomodulators is effective for inducing remission but no controlled dat…

medicine.medical_specialtyCombination therapyAzathioprineDiseasechemistry.chemical_compoundMesalazineAdjuvants ImmunologicCrohn DiseaseClinical endpointMedicineHumansPharmacology (medical)Prospective StudiesIntensive care medicinePharmacologyCrohn's diseaseBiological ProductsClinical Trials as Topicbusiness.industryTumor Necrosis Factor-alphaRemission InductionGeneral Medicinemedicine.diseaseReview articleSurgeryClinical trialchemistryPractice Guidelines as TopicDrug Therapy CombinationbusinessImmunosuppressive Agentsmedicine.drugExpert opinion on pharmacotherapy
researchProduct

Response to "The combination therapy with cytapheresis plus vedolizumab in a corticosteroid-dependent patient with ulcerative colitis and previous An…

2018

medicine.medical_specialtyCombination therapymedicine.drug_class030204 cardiovascular system & hematologyAntibodies Monoclonal HumanizedGastroenterologyVedolizumab03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesInternal medicinemedicineHumansColitisHepatologybusiness.industryTumor Necrosis Factor-alphaGastroenterologymedicine.diseaseUlcerative colitisCytapheresisMonoclonalCorticosteroidTumor necrosis factor alphaColitis UlcerativebusinessCytapheresis030215 immunologymedicine.drugDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Neuro-radiosurgery treatments: MRI brain tumor seeded image segmentation based on a cellular automata model

2016

Gross Tumor Volume (GTV) segmentation on medical images is an open issue in neuro-radiosurgery. Magnetic Resonance Imaging (MRI) is the most promi-nent modality in radiation therapy for soft-tissue anatomical districts. Gamma Knife stereotactic neuro-radiosurgery is a mini-invasive technique used to deal with inaccessible or insufficiently treated tumors. During the planning phase, the GTV is usually contoured by radiation oncologists using a manual segmentation procedure on MR images. This methodology is certainly time-consuming and op-erator-dependent. Delineation result repeatability, in terms of both intra- and inter-operator reliability, is only obtained by using computer-assisted appr…

medicine.medical_specialtyComputer sciencemedicine.medical_treatment02 engineering and technologyCellular AutomataBrain tumors; Cellular automata; Gamma knife treatments; MR imaging; Semi-automatic segmentationBrain tumorsRadiosurgery030218 nuclear medicine & medical imagingTheoretical Computer Science03 medical and health sciences0302 clinical medicineGamma Knife treatments0202 electrical engineering electronic engineering information engineeringmedicineSegmentationMri brainModality (human–computer interaction)medicine.diagnostic_testSemi-automatic segmentationbusiness.industryINF/01 - INFORMATICAMagnetic resonance imagingImage segmentationCellular automatonRadiation therapyBrain tumor020201 artificial intelligence & image processingGamma Knife treatmentArtificial intelligenceRadiologybusinessMR imaging
researchProduct

Head–Neck Cancer Delineation

2021

Head–Neck Cancer (HNC) has a relevant impact on the oncology patient population and for this reason, the present review is dedicated to this type of neoplastic disease. In particular, a collection of methods aimed at tumor delineation is presented, because this is a fundamental task to perform efficient radiotherapy. Such a segmentation task is often performed on uni-modal data (usually Positron Emission Tomography (PET)) even though multi-modal images are preferred (PET-Computerized Tomography (CT)/PET-Magnetic Resonance (MR)). Datasets can be private or freely provided by online repositories on the web. The adopted techniques can belong to the well-known image processing/computer-vision a…

medicine.medical_specialtyComputer sciencemedicine.medical_treatmentImage processinghead–neck cancer (HNC)Head neck cancerlcsh:Technology030218 nuclear medicine & medical imagingTask (project management)head and neck squamous cell carcinoma (HNSCC)lcsh:Chemistry03 medical and health sciencestumor delineation0302 clinical medicinemedicineGeneral Materials ScienceMedical physicsSegmentationlcsh:QH301-705.5InstrumentationSettore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniFluid Flow and Transfer Processesmedicine.diagnostic_testlcsh:Tbusiness.industryProcess Chemistry and TechnologyDeep learningsegmentationGeneral EngineeringCT Head and neck squamous cell carcinoma (HNSCC) Head–neck cancer (HNC) MRI Nasopharyngeal cancer (NPC) PET Segmentation Tumor delineationnasopharyngeal cancer (NPC)lcsh:QC1-999Computer Science ApplicationsRadiation therapylcsh:Biology (General)lcsh:QD1-999lcsh:TA1-2040Positron emission tomography030220 oncology & carcinogenesisArtificial intelligenceTomographylcsh:Engineering (General). Civil engineering (General)businesslcsh:PhysicsCTApplied Sciences
researchProduct

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (…

2015

ABSTRACT The DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) aims to provide recommendations for definitions of time-to-event end points in cancer randomized controlled trials. We relied on a consensus method based on a multidisciplinary panel of experts to develop these guidelines for trials on sarcomas and gastrointestinal stromal tumors. Background The use of potential surrogate end points for overall survival, such as disease-free survival (DFS) or time-to-treatment failure (TTF) is increasingly common in randomized controlled trials (RCTs) in cancer. However, the definition of time-to-event (TTE) end points is rarely precise and lacks unif…

medicine.medical_specialtyConsensusTime FactorssarcomaDelphi TechniqueEndpoint Determination[SDV]Life Sciences [q-bio]Disease-Free Survivallaw.invention03 medical and health sciencesgastrointestinal stromal tumors0302 clinical medicineRandomized controlled trialSDG 3 - Good Health and Well-beinglawMultidisciplinary approachTerminology as TopicmedicineHumansMedical physicsTreatment Failureguidelinestime-to-event end pointComputingMilieux_MISCELLANEOUSRandomized Controlled Trials as Topic030304 developmental biologyEvent (probability theory)0303 health sciencesEnd pointGiSTSurrogate endpointbusiness.industryefficacy measureCancerHematologymedicine.disease3. Good healthOncologyResearch Design030220 oncology & carcinogenesisrandomized controlled trialDisease ProgressionRadiologySarcomabusiness
researchProduct

Non-invasive diagnosis and grading of postsurgical endoscopic recurrence in Crohn's disease

2010

Abstract Non-invasive techniques aim to be an alternative to endoscopy in the assessment of postsurgical recurrence of Crohn's disease (CD). The object of this study was to evaluate the accuracy of abdominal ultrasonography (AUS) and 99m Tc-hexamethylpropylene amineoxime ( 99m Tc-HMPAO)-labelled leucocyte scintigraphy (LLS) compared with endoscopy in the diagnosis and grading of postsurgical recurrence of CD. Between January 2006 and May 2007, all patients with CD and resection with ileocolic anastomosis were included prospectively. Within three days they underwent an ileocolonoscopy, AUS with evaluation of bowel wall thickness and the presence of Doppler flow, and LLS. Forty patients who m…

medicine.medical_specialtyCrohn's diseasemedicine.diagnostic_testbusiness.industryGastroenterologyGeneral MedicineAnastomosismedicine.diseaseEndoscopyPositive predicative valueAbdominal ultrasonographyparasitic diseasesSeverity of illnessmedicineRadiologybusinessProspective cohort studyGrading (tumors)Journal of Crohn's and Colitis
researchProduct

Sjøgren's syndrome-associated oxidative stress and mitochondrial dysfunction: Prospects for chemoprevention trials

2012

An involvement of oxidative stress (OS) was found in recent studies of Sjøgren's syndrome (SS) that reported significant changes in protein oxidation, myeloperoxidase activity, TNF-α, nitrotyrosine, and GSH levels in plasma from SS patients. Excess levels of OS markers, as oxidative DNA damage and propanoyl-lysine, were reported in saliva from SS patients. Previous reports concurred with a role of OS in SS pathogenesis, by showing a decreased expression of antioxidant activities in conjunctival epithelial cells of SS patients and in parotid gland tissue samples from SS patients. A link between OS and mitochondrial dysfunction (MDF) is recognized both on the grounds of the established role o…

medicine.medical_specialtyDNA damageMitochondrionBiologyProtein oxidationmedicine.disease_causeChemopreventionBiochemistryPathogenesischemistry.chemical_compoundInternal medicinemedicineHumansSalivaPeroxidasechemistry.chemical_classificationReactive oxygen speciesTumor Necrosis Factor-alphaNitrotyrosineAutoantibodyGeneral MedicineGlutathioneMitochondriaOxidative StressSjogren's SyndromeEndocrinologychemistryTyrosineBiomarkersOxidative stressDNA DamageFree Radical Research
researchProduct